ASO titre Quantitative Serum Test

COVIPROTECT gives you exact measurement of the antibody titres available in your body against Spike Protein either post vaccination or post infection of COVID 19. The spike protein antibodies are generally developed after 2 weeks of second dose of vaccination or 4 weeks of exposure to infection. Having said that, certain individuals developed Spike protein antibodies even after first vaccine dose itself.
On the other hand, Qualitative Test gives you an idea whether Antibodies are present or absent without the actual titre. Its use is limited in knowing the exposure status than to the actual titre. With advent of COVIPROTECT, it is likely that the qualitative test would become obsolete soon.

• SARS CoV2 Antibody Quantitative (COVIPROTECT) (MRP- INR 1200), (Home visit charges Extra)
• SARS CoV2 Antibody Qualitative (MRP- INR 450), (Home visit charges Extra)

Blood (Serum)

TAT (Turnaround time)- Report availability within 24 hours

• It is advisable to test for the neutralizing antibodies after 21 to 28 days’ post-natural infection by SARS CoV-2 and 15 days post the second dose of COVID-19 vaccination for detectable levels of antibodies to appear.3

• Quantitative tests edge over other qualitative tests in the market.
• Offers better sensitivity & specificity.
• Excellent concordance with Neutralizing Antibodies
• It can aid the authorities to establish the vaccination strategy.
• It can help determine the eligibility of plasma donors with its plasma therapy cut off.
• Faster turnaround time, report availability within 24 hours

Currently, for Anti-body testing Metropolis has the capacity of doing 50,000 tests every day and plans to expand to 75,000 tests daily. With increasing demand, it plans to expand antibody testing through 45 labs across India, including smaller cities.

Apart from the above, Metropolis also provides

• The assurance of safe and hygienic blood collection.
• Kits and systems of global standards for ensuring accurate reports.
• Most competent pricing to enable testing by all.
• Value-added services like trend analysis, detailed report interpretation and data-analytics.

As the number of COVID-19 cases seem to be rising, people would want to know if they have developed immunity to the virus post exposure or vaccination. COVIPROTECT will help understand these situations particularly those who are vulnerable to the infection.